Combined therapy increases life expectancy in metastatic colorectal cancer patients.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary* / Q000601:surgery; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable; D007261:Infusions, Intra-Arterial; D008017:Life Expectancy; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary* / Q000601:surgery; D008297:Male; D015996:Survival Rate
D000970:Antineoplastic Agents